Going viral on Wall St | Merkel wannabes | A comedy of errors

Hopping on the Corona bandwagon

This Friday, German biotech company CureVac listed on the NASDAQ stock exchange in an IPO. The shares soared - at the end of the day the company was worth nine Billion Euros.

When CureVac in January announced that they were working on a Covid vaccine, no one took notice. Not that CureVac was unknown, five years earlier a €4…